Sfoglia per Autore
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease
2004-01-01 LETO G; CRESCIMANNO M; FLANDINA C; TUMMINELLO FM; ARCARA C; BADALAMENTI G; GEBBIA N; VIZZINI L; FULFARO F
Weekly paclitaxel and Pegylated liposomal doxorubicin as first line treatment in metastatic breast cancer patients
2004-01-01 FULFARO F; VALERIO MR; BADALAMENTI G
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer
2004-01-01 BADALAMENTI G; VALERIO MR; RINALDI G; ARCARA C; CICERO G; VIZZINI L; TRAVAGLIATO MG; INTRIVICI C; RUSSO A; GULOTTA G; GEBBIA N; FULFARO F
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer
2004-01-01 AMATO A; SISTO PS; CASCIO S; CORSALE S; MIGLIAVACCA M; CAL V; LA ROCCA G; AGNESE V; TOTARO MS; CAMMARERI P; GREGORIO V; BRUNO L; BAZAN V; VALERIO MR; FURFARO F; ARCARA C; BADALAMENTI G; AGNELLO G; GEBBIA N; RUSSO A
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes
2004-01-01 VALERIO MR; RINALDI G; BADALAMENTI G; ARCARA C; CICERO G; SORTINO C; SPINNATO F; MAIORANA O; COCCHIARA A; RUSSO A; GULOTTA G; GEBBIA N; FULFARO F
Cardiotossicità e Cardioprotezione.
2004-01-01 FULFARO, F; DI FEDE, G; BAJARDI, E; CICERO, G; VALERIO, MR; RINALDI, G; BADALAMENTI, G; GEBBIA, N
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004-01-01 VALERIO MR; FULFARO F; BADALAMENTI G; ARCARA C; CICERO G; DANGELO G; CROSTA A; BENFANTE B; SPINNATO F; RUSSO A; DI FEDE G; GEBBIA N
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes
2004-01-01 GEBBIA N; FULFARO F; BADALAMENTI G
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation
2004-01-01 AMATO A; SISTO PS; CASCIO S; CORSALE S; MIGLIAVACCA M; CAL V; LA ROCCA G; AGNESE V; TOTARO MS; CAMMARERI P; GREGORIO V; BRUNO L; BAZAN V; VALERIO MR; FULFARO F; ARCARA C; BADALAMENTI G; AGNELLO G; GEBBIA N; RUSSO A
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004-01-01 FULFARO F; VALERIO MR; BADALAMENTI G; ARCARA C; CICERO G; RINALDI G; ACCARDO A; INTRIVICI C; CROSTA A; SCIBILIA C; RUSSO A; DI FEDE G; GEBBIA N
The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation.
2005-01-01 INTRIVICI C; VIZZINI L; TRAVAGLIATO MG; PIZZO T; BADALAMENTI G; ARCARA C; CICERO G; RINALDI G; CROSTA A; SPINNATO F; VALERIO MR; FULFARO F
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER
2005-01-01 INCORVAIA L; SFERRAZZA C; DI FEDE G; BADALAMENTI G; ROTOLO G; FRICANO S; DI LORENZO G; LETO G; GEBBIA N; RINI GB
Tumor markers in urogynaecological tumors.
2005-01-01 Leto, G; Incorvaia, L; Badalamenti, G; Arcara, C; Fulfaro, F; Tumminello, FM; Flandina, C; Crescimanno, M; Gebbia, N
Surgical Treatment of Extravasation Injuries
2005-01-01 NAPOLI, P; CORRADINO, B; FULFARO, F; TRIPOLI, M; VIENI, S; BADALAMENTI, S; CORDOVA, A; MOSCHELLA, F; Vieni, S.
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers
2005-01-01 FULFARO F; LETO G; BADALAMENTI G; ARCARA C; CICERO G; VALERIO MR; DI FEDE G; RUSSO A; VITALE A; RINI GB; CASUCCIO A; INTRIVICI C; GEBBIA N
LIVELLI CIRCOLANTI DI ACTIVINA A IN PAZIENTI CON OSTEOPOROSI PRIMITIVA O METASTASI OSSEE DA CARCINOMA MAMMARIO
2005-01-01 INCORVAIA L; SFERRAZZA C; DI FEDE G; BADALAMENTI G; ROTOLO G; FRICANO S; DI LORENZO G; LETO G; GEBBIA N; RINI GB
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer
2005-01-01 L INCORVAIA; C SFERRAZZA; G DI FEDE; G BADALAMENTI; G ROTOLO; S FRICANO; G DI LORENZO; LETO G; N GEBBIA AND GB RINI
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation
2006-01-01 VALERIO MR; CICERO G; SCIBILIA C; ADILE C; CROSTA A; ARCARA C; BADALAMENTI G; VIZZINI L; SPINNATO F; INTRIVICI C; FULFARO F
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer.
2006-01-01 CALCARA D; GREGORIO V; CORSALE S; CALO V; AGNESE V; AUGELLO C; BRUNO L; GARGANO G; GULLO A; LA PAGLIA L; SCHIRO; V; TERRASI M; CROSTA A; BADALAMENTI G; FRICANO S; NAPOLI L; GIORDANO A; TOMASINO RM; MORELLO V; DANIELE E; CHIARINI A; MARTORANA A; GEBBIA N; BAZAN V; RUSSO A
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
2006-01-01 VERDERAME, F; RUSSO, A; DI LEO, R; BADALAMENTI, G; SANTANGELO, D; CICERO, G; VALERIO, MR; GULOTTA, G; TOMASELLO, G; GEBBIA, N; FULFARO, F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile